Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Miscellaneous Drugs

These sections summarize data on metformin, fluvoxamine, and other miscellaneous drugs.

Summary Recommendations

Miscellaneous drugs that have been evaluated as treatments for COVID-19

Colchicine

Results from evaluations of colchicine in patients with COVID-19

Fluvoxamine

Information on the clinical trials that evaluated the use of fluvoxamine in patients with mild to moderate COVID-19

Intravenous Immunoglobulin

Information on the clinical trials that examined the use of IVIG in patients with COVID-19

Ivermectin

Data from studies that evaluated ivermectin in patients with COVID-19

Metformin

Data from studies that evaluated metformin in patients with mild to moderate COVID-19

Table: Characteristics of Miscellaneous Drugs

Characteristics of miscellaneous drugs evaluated in COVID-19 clinical trials